Nanjing Hicin Pharmaceutical Co (SZSE:300584) FCF Margin % : -23.56% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing Hicin Pharmaceutical Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nanjing Hicin Pharmaceutical Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-24.6 Mil. Nanjing Hicin Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥104.6 Mil. Therefore, Nanjing Hicin Pharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2024 was -23.56%.

As of today, Nanjing Hicin Pharmaceutical Co's current FCF Yield % is -9.15%.

The historical rank and industry rank for Nanjing Hicin Pharmaceutical Co's FCF Margin % or its related term are showing as below:

SZSE:300584' s FCF Margin % Range Over the Past 10 Years
Min: -42.69 Med: -3.6 Max: 11.44
Current: -34.37

During the past 12 years, the highest FCF Margin % of Nanjing Hicin Pharmaceutical Co was 11.44%. The lowest was -42.69%. And the median was -3.60%.

SZSE:300584's FCF Margin % is ranked worse than
82.54% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 0.16 vs SZSE:300584: -34.37

Nanjing Hicin Pharmaceutical Co FCF Margin % Historical Data

The historical data trend for Nanjing Hicin Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Hicin Pharmaceutical Co FCF Margin % Chart

Nanjing Hicin Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

5.83

-6.61

-5.96

-42.69

-33.46

Nanjing Hicin Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-20.73	-38.85	-34.45	-37.76	-23.56

Competitive Comparison of Nanjing Hicin Pharmaceutical Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Nanjing Hicin Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanjing Hicin Pharmaceutical Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanjing Hicin Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nanjing Hicin Pharmaceutical Co's FCF Margin % falls into.

Nanjing Hicin Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nanjing Hicin Pharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-173.289	/	517.832
	=	-33.46 %

Nanjing Hicin Pharmaceutical Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-24.639	/	104.562
	=	-23.56 %

Nanjing Hicin Pharmaceutical Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nanjing Hicin Pharmaceutical Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Hicin Pharmaceutical Co Ltd (SZSE:300584) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Heng Road 1, Nanjing Economic and Technological Development Zone, Jiangsu Province, Nanjing, CHN, 210009

Website

http://www.hicin.cn

Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.

Executives

Cao Yu Ping	Directors, executives
Yan Mei Qiang	Directors, executives
Jiang Xiang Ming	Executives
Gu Hai	Independent director

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Headlines

No Headlines